STEEL Percutaneous Coronary Intervention
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT02327624
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 180 participants
- Registry
-
NCT02327624
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02327624. Randomized; no masking; primary purpose treatment. Start 2015-06 (actual); primary completion 2018-05-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STEEL Percutaneous Coronary Intervention
- Acronym
- STEEL-PCI
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Ticagrelor 60
- Intervention (Drug)
- Ticagrelor 90
- Lead sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct02327624- Content hash
d351631c1898e27bd498de1c85cc04b0e175f2d4d88fbac0d69f459a95ff4141